FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion.
Rogers
Lee F
LF
Department of Radiology, University of Arizona Health Sciences Center, 1501 N Campbell Ave., PO Box 245067, Tucson, AZ 85724-5067, USA. lfrogers@comcast.net
Taljanovic
Mihra
M
D004164:Diphosphonates / Q000009:adverse effects*; D005264:Femoral Fractures / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration
D004164:Diphosphonates